Observational Protocol: Trametinib therapy for Symptomatic Patients with RAS/MAPK-Pathway Mutation-Positive Disorders
Details
Age
Child to Adult
Type of Study
Observational
Locations
Childrens Hospital Colorado
Principal Investigator
Taizo Nakano, MD
Study ID
Protocol Number: 21-3183
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers